Hydrocortisone Hemisuccinate

Back to search

Molecule Structure

Scientific Name

Hydrocortisone Hemisuccinate

Description of the Drug

Hydrocortisone succinate is a corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14545

Brand Name(s)

Not Available

Company Owner(s)

Baxter Healthcare Corp Anesthesia And Critical Care, Watson Laboratories Inc, Hospira Inc, Abraxis Pharmaceutical Products, International Medication Systems Ltd, Abbott Laboratories Pharmaceutical Products Div, Hospira Worldwide, Inc, Abbott Laboratories Hosp Products Div, Pharmacia And Upjohn Co

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Glucocorticoid receptor SINGLE PROTEIN AGONIST CHEMBL2034

Unichem Links

SureChEMBL SCHEMBL7664
DrugBank DB14545
PubChem: Thomson Pharma 15478880
PubChem 16623
LINCS LSM-5816
Nikkaji J7.358J
BindingDB 50016931
EPA CompTox Dashboard DTXSID40872905
LipidMaps LMST02030126
DrugCentral 4456
ChemicalBook CB4482734
rxnorm A-HYDROCORT CORTISOL SUCCINATE HYDROCORTISONE SODIUM SUCCINATE SOLU-CORTEF
ChEBI 31677
ZINC ZINC000004097472